🔗 Share this article

A shadow market for unapproved weight-loss drugs is propelled by TikTok fitness influencers and vendors on messaging platforms, based on recent findings.

Experimental Drug Acquiring Traction Via Social Media

The experimental drug, which remains in research studies, is being advertised by online personalities for its alleged fat-burning properties. Followers are urged to message these profiles privately for source information, while also receiving discount codes.

Active Trade on Messaging Platforms

Separately, a robust trade exists on messaging services, where communities with thousands of participants share comparison images, injection guides and claims of next-day UK delivery. Sellers market the drug there before redirecting customers to WhatsApp for purchases.

Understanding Retatrutide

Retatrutide is an experimental injection created by US drugmaker Eli Lilly. The drug targets three intestinal hormones – GLP-1, GIP and glucagon. Preliminary studies suggest it could assist patients reduce up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being hailed digitally as the next Ozempic.

Medical Professionals Voice Concerns

However, physicians and chemists have cautions that the distribution of what remains an unlicensed drug in the United Kingdom is worrisome and could result in individuals injecting substances of unknown origin.

Several experts said the popularity for retatrutide could be connected to the increasing cost of approved weight loss treatments such as Mounjaro.

Regulatory Position and Enforcement

Selling retatrutide on TikTok or Telegram is illegal in the UK, as it is an unlicensed drug that must not be marketed or supplied for personal consumption under the British medical regulations.

Some influencers attempt to circumvent the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but promotion and supply can still breach medicines, advertising, and customer regulations, potentially leading to penalties, legal action or prison.

Service Response and Content Removal

Based on TikTok, the platform has removed violative material and banned related hashtags and query recommendations. The organization stated it was committed to maintaining the service safe and investing in strengthening compliance measures.

Digital Marketplace Activities

Investigations also found groups with up to nine thousand members selling retatrutide using Telegram's integrated search feature, which functions like a online catalog. Entering “retatrutide” immediately displays channels with thousands of members, populated with photos of weight loss, glowing reviews and step-by-step instructions for preparing or administering at residence.

After minutes of entering one group, a vendor posted contact information, where most transactions occur. The vendor sent an instruction manual and guaranteed delivery within 48 hours. When asked whether the substance was genuine, one seller responded: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. None asked about weight, medical conditions or previous experience.

Product Information and Pricing

Inside these communities, posts display dark colored parcels with postal service labels, stating to contain fresh supplies. One message read: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, mixed at residence with purified liquid, or pre-filled injectors usually priced at 160 pounds for 20mg. When asked how much time a injector should be used, sellers give conflicting answers varying between a several days to “depends on your body”.

Platform Moderation and Safety Actions

A spokesperson for the messaging service said it regularly monitored dangerous content on its service including content that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“People are injecting substances they cannot confirm. Even if the research behind this drug is valid, these online products may not contain what they claim,” stated a pharmacy expert, the director of pharmacy at a pharmacy service.

A medical professional of Asda Online Doctor connected the surge in demand to recent cost increases for approved slimming drugs such as Mounjaro. “With prices increasing, individuals are turning to online platforms. But fake injections are extremely risky. You cannot know what’s inside or whether the conditions they were produced in was sterile,” she said.

Her staff has already seen patients injured by self-injection from unverified suppliers. “We understand the disappointment, but buying from messaging apps or WhatsApp is gambling with your health,” said the doctor. “These substances could be impure or improperly measured.”

Producer Statement

A spokesperson from Eli Lilly said the substance was in phase 3 clinical trials and had not been evaluated or approved by any regulatory agency globally. “Therefore at this time no one can market [it] for human use,” they said, adding that any product “falsely representing itself as a company experimental product not yet authorized … may subject patients to potentially serious medical dangers”.